Sponsor CCFA

Many of the Crohn's & Colitis Foundation of America’s (CCFA) cutting-edge research investigations are funded through donor sponsorships. Become part of the cures by funding (in full or in part), one of the more than 200 research projects that are currently underway. In recognition of your generous support, we will be pleased to name a research investigation of your choice in honor of you, a family member, a loved one, or a physician.  

The following lists the different levels of naming opportunities that are available:

Senior Grants Program 

  • Senior Research Award (Full Sponsorship: $150,000; Partial Sponsorship: $50,000)—These grants are awarded to the established senior investigators of projects that are conducted at hospitals, universities, and research laboratories around the world. 

Research Training Awards Program

  • Career Development Award (Full Sponsorship: $100,000; Partial Sponsorship: $35,000)—Candidates for these awards must be employed by an academic institution within the United States and have 5 to 10 years of post-doctoral experience, including 2 years of relevant research experience. The research project must be in the field of inflammatory bowel disease (IBD).
  • Research Fellowship Award (Full Sponsorship: $65,000; Partial Sponsorship: $25,000)—Candidates must be employed by an academic institution within the United States and have at least 2 years of post-doctoral experience. The research project should be in the field of IBD. 
  • Student Research Fellowship Award (Full Sponsorship: $3,000)—Candidates for these awards are undergraduate, medical, or graduate students at accredited institutions within the United States. They conduct full-time research for a minimum of 10 weeks with a mentor investigating a subject relevant to IBD.

Why Sponsor CCFA?

Every year, CCFA's National Scientific Advisory Committee (NSAC), comprised of thought leaders in IBD, conducts a strenuous peer review. Grants are awarded on the basis of scientific merit, relevance to IBD, and the qualifications of the investigators. In fact, CCFA only funds the very best IBD research, no matter where that may be. By supporting the best and brightest researchers, your investment in CCFA is an investment in our quest for the cures.  

These dedicated scientists are working diligently to unravel the clues to understanding IBD. Please remember, in gratitude for your generosity, we will also list your name in our annual report send you regular progress reports, and give you the opportunity to meet with the researcher(s) you support.

CCFA prides itself on playing an integral role in many of the discoveries that have improved the lives of those afflicted with Crohn's disease and ulcerative colitis. In the past 40 years, we have funded over 1,300 research awards that have contributed significantly to the basic and clinical research geared towards finding cures. Research awards have helped to define the current hypothesis of what causes IBD,  the interplay of genetics, environment, and the immune system accounts for the initiation and perpetuation of Crohn's disease or ulcerative colitis. 

These theories have laid the groundwork for more focused research. For example, early research on TNF-alpha, which contributed to the development of infliximab, was funded by CCFA. Our funding has also provided early career training for many of the investigators involved in the discovery of the IL-23 gene's role in IBD. Comparative drug trials have been sponsored by CCFA in order to find new uses for existing therapies such as azathioprine, prednisone, and the combination of infliximab with methotrexate.   

We hope you will join us in the battle to cure Crohn's disease and ulcerative colitis by making a generous gift to support IBD research. For more information on supporting our vital research, please contact your local chapter or the major gift department at CCFA National Headquarters at 1-800-932-2423, ext. 248.